a Antibody Generation Group, Research Division , Chugai Pharmabody Research Pte. Ltd , Singapore.
b Discovery Biologics Department, Research Division , Chugai Pharmaceutical Co., Ltd ., Gotemba , Shizuoka , Japan.
MAbs. 2019 May/Jun;11(4):632-638. doi: 10.1080/19420862.2019.1583996. Epub 2019 Mar 21.
The complex molecular formats of recent therapeutic antibodies, including bispecific antibodies, antibody fragments, and other fusion proteins, makes the task of purifying the desired molecules in a limited number of purification steps more and more challenging. Manufacturing these complicated biologics can be substantially improved in the affinity capture stage if the simple bind-and-elute mode is accompanied by targeted removal of the impurities, such as mis-paired antibodies and oligomers or aggregates. Here, we report a method, based on the binding valency to Protein L resin, of separating proteins during the elution step by simply controlling the conductivity at low pH. We show that the method efficiently separated targeted antibodies from mis-paired and aggregated species. Notably, the number of Protein L binding sites can be built into the molecule by design to facilitate the purification. This method may be useful for purifying various antibody formats at laboratory and manufacturing scales.
近年来治疗性抗体(包括双特异性抗体、抗体片段和其他融合蛋白)的复杂分子结构使得在有限的纯化步骤中纯化所需分子的任务变得越来越具有挑战性。如果简单的结合-洗脱模式伴随着目标杂质(如配对错误的抗体和寡聚物或聚集体)的去除,制造这些复杂的生物制剂在亲和捕获阶段可以得到实质性的改进。在这里,我们报告了一种方法,即在低 pH 值下通过简单控制电导率,基于与 Protein L 树脂的结合价,在洗脱步骤中分离蛋白质。我们表明,该方法可以有效地将靶向抗体与配对错误和聚集的物质分离。值得注意的是,通过设计可以将 Protein L 结合位点的数量构建到分子中,以方便纯化。该方法可用于在实验室和生产规模下纯化各种抗体形式。